Versatope Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Versatope Therapeutics's estimated annual revenue is currently $4.2M per year.
- Versatope Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Versatope Therapeutics has 27 Employees.
- Versatope Therapeutics grew their employee count by 29% last year.
Versatope Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Co-Founder | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | VP, Head Research and Development | Reveal Email/Phone |
5 | Head Quality Assurance | Reveal Email/Phone |
6 | Director CMC and Process Development | Reveal Email/Phone |
7 | Director Business Operations | Reveal Email/Phone |
8 | Project and Alliance Manager | Reveal Email/Phone |
9 | Process Development Scientist | Reveal Email/Phone |
10 | Senior Process Technician | Reveal Email/Phone |
Versatope Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Versatope Therapeutics?
Versatope Therapeutics is an infectious disease company with two lead development programs and others at the preclinical stage. Versatope delivers immunity by customizing nano-size vesicles by using synthetic biology for biopharmaceutical applications.
keywords:N/AN/A
Total Funding
27
Number of Employees
$4.2M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.4M | 27 | 0% | $145M |
#2 | $5.3M | 28 | 12% | N/A |
#3 | $5.6M | 28 | 8% | N/A |
#4 | $2.8M | 28 | N/A | N/A |
#5 | $6.5M | 28 | 4% | N/A |